Utah Medical Products, Inc. (UTMD) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Utah Medical Products, Inc. (UTMD) Healthcare & Pipeline Overview

Utah Medical Products is a specialized healthcare-device manufacturer serving labor and delivery, neonatal intensive care, women’s health, and selected hospital procedures. Its portfolio combines disposable catheters, monitoring accessories, electrosurgical systems, gynecological instruments, and procedure kits, supported by direct service, sales teams, consultants, and manufacturer representatives.

What Is the Investment Thesis for UTMD?

UTMD's research profile is defined by specialized medical-device manufacturing, a broad portfolio of disposable and capital-linked procedure products, and exposure to recurring clinical workflows in labor and delivery, neonatal intensive care, and women's health. Reported gross margin is 53.6%, profit margin is 28.9%, and P/E is 18.4, providing measurable indicators of profitability and valuation. Market capitalization is $0.22 billion, while beta of 0.36 indicates relatively low reported share-price sensitivity compared with a beta of 1, although no benchmark or observation period is provided. Potential value drivers include cross-selling across hospital departments, continued use of established product families, and distribution through multiple channels, including direct sales, consultants, and manufacturer representatives. The portfolio spans monitoring accessories, catheters, procedure trays, electrosurgical systems, gynecological instruments, urinary-care devices, and neonatal products, which may provide multiple product-level revenue sources. However, the supplied information contains no revenue-growth rate, earnings-growth forecast, geographic expansion plan, backlog, research-and-development spending, regulatory pipeline, debt figures, cash-flow data, or analyst price targets. Key analytical risks include the company's concentration in specialized clinical categories, unknown regulatory and reimbursement conditions, and the absence of quantified product-level or geographic performance data. These facts are presented for independent research rather than as a recommendation.

Based on FMP financials and quantitative analysis

UTMD Key Highlights

Market capitalization of $227M, indicating a small-cap medical-device company based on the provided fundamentals.

• Gross margin of 53.6%, reflecting the reported difference between sales and cost of goods sold; revenue and cost figures are Unknown.
• Profit margin of 28.9%, indicating reported net profitability; net income and revenue amounts are Unknown.
• P/E ratio of 18.4, providing a reported earnings-based valuation metric without a supplied historical or peer comparison.
• Beta of 0.36 and dividend yield of 1.93%, representing the supplied share-volatility and dividend metrics; dividend per share and payout ratio are Unknown.

Who Are UTMD's Competitors?

UTMD is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are UTMD's Key Strengths?

Diversified portfolio of medical devices serving labor and delivery, neonatal intensive care, women's health, and other hospital procedures.

• Reported gross margin of 53.6% and profit margin of 28.9%.
• Established since 1978 with 155 employees and headquarters in Midvale, Utah.
• Multiple distribution routes and products spanning disposable, procedural, monitoring, electrosurgical, and specialty categories.

What Are UTMD's Weaknesses?

Small reported market capitalization of $227M relative to larger medical-device companies.

• Substantial portfolio exposure to specialized maternity-care and women's-health categories.
• The supplied data does not quantify revenue diversification, geographic reach, customer concentration, or product-level growth.
• The source provides no information on research-and-development spending, regulatory pipeline, debt, cash flow, or backlog.

What Could Drive UTMD Stock Higher?

UTMD catalyst: Continued supply of labor-and-delivery and neonatal intensive-care products through UTMD's established customer and distribution channels.

• Product breadth in women's health, including electrosurgical systems, laparoscopic instruments, uterine-assessment devices, contraception products, and urinary-care systems.
• Cross-selling potential across hospitals, outpatient clinics, physicians' offices, labor-and-delivery wards, neonatal intensive care units, and women's-health centers.
• Continued demand for disposable catheters, filters, pressure transducers, dialysis sets, feeding devices, urinary drainage systems, and procedure trays.

What Are the Key Risks for UTMD?

Regulatory approval, compliance, or product-quality requirements affecting medical devices; specific pending matters are Unknown.

• Competitive pressure from other suppliers of labor-and-delivery, neonatal, women's-health, gynecological, urinary-care, and hospital-procedure products.
• Customer concentration or purchasing pressure among hospitals, clinics, and physicians' offices; customer-level exposure is Unknown.
• Substantial portfolio exposure to women's health and gynecological interventions, with category-level revenue dependence not provided.
• Limited disclosed financial and operating detail in the supplied data, including Unknown revenue, earnings, cash flow, debt, geographic mix, research-and-development spending, and market share.

What Are the Growth Opportunities for UTMD?

• Ongoing: Expansion across labor-and-delivery workflows is a potential product-level growth avenue because UTMD already supplies fetal monitoring accessories, vacuum-assisted delivery systems, and other childbirth tools. The company can also serve adjacent maternity-care needs through its neonatal and women's-health portfolios. The source data does not provide a labor-and-delivery market size, UTMD revenue by category, product adoption rate, or a stated expansion timeline, so market size and timing are Unknown. The relevant differentiator is the existing concentration of products around childbirth-related clinical settings.
• Ongoing: Neonatal intensive care provides an established clinical area for UTMD's DISPOSA-HOOD, GESCO, PALA-NATE, and MYELO-NATE products. A broader neonatal portfolio could support additional hospital relationships or increased use across procedures, but no pipeline, approval schedule, unit volume, or neonatal-care market estimate is provided. Market size and timeline are Unknown. The available evidence supports only that UTMD already serves neonatal intensive care units and offers multiple specialized devices designed for newborn respiratory, vascular, oral-protection, and lumbar-sampling applications.
• Ongoing: Women's health and gynecological interventions represent a substantial portion of UTMD's product range. LETZ, FINESSE+, specialized electrodes, FILTRESSE, Femcare laparoscopic instruments, Filshie Clip, PATHFINDER PLUS, LIBERTY, ENDOCURETTE, TVUS/HSG-Cath, and LUMIN give the company multiple products across electrosurgery, laparoscopy, contraception, urinary care, uterine assessment, and uterine manipulation. The source does not provide market size, geographic opportunity, competitive share, or a stated commercialization timeline; each is Unknown. Product breadth is the identifiable strategic asset in this area.
• Ongoing: Cross-selling through UTMD's mixed distribution model could support growth across hospitals, outpatient clinics, physicians' offices, and specialized departments. The company uses direct customer service and sales teams, independent consultants, and manufacturer representatives, creating several routes to reach healthcare customers. However, the provided data does not quantify channel productivity, customer acquisition, geographic coverage, sales-force expansion, or future timing. Market size and timeline are Unknown. The identifiable opportunity is to place multiple product categories with organizations that require labor, neonatal, women's-health, and procedural supplies.
• Ongoing: Development or broader utilization of disposable and procedure-oriented products could create recurring demand within existing clinical workflows. UTMD supplies disposable pressure transducers, filters, catheters, dialysis sets, urinary drainage systems, feeding devices, procedure trays, and electrosurgical accessories in addition to reusable or equipment-linked products. The source provides no consumable replacement rate, recurring-revenue percentage, research-and-development program, new-product schedule, or addressable-market estimate. Market size and timeline are therefore Unknown. The identifiable opportunity is the breadth of disposable products across several healthcare settings.

What Are UTMD's Competitive Advantages?

• Specialized product knowledge across labor and delivery, neonatal intensive care, and women's health.
• Broad portfolio spanning disposable supplies, monitoring accessories, electrosurgical systems, procedure trays, and specialty instruments.
• Established company history dating to 1978, according to the provided data.
• Multiple distribution channels, including direct sales and service, independent consultants, and manufacturer representatives.
• Product coverage across several clinical departments and healthcare settings, enabling potential portfolio breadth within institutional customers.

What Does UTMD Do?

Utah Medical Products, Inc. is a healthcare technology company focused on creating, producing, and supplying medical devices for the healthcare sector. Established in 1978, the company is headquartered in Midvale, Utah, and has 155 employees. Its product portfolio is concentrated in clinical areas that include labor and delivery, neonatal intensive care, women's health, gynecological interventions, urinary care, dialysis, feeding, blood-pressure monitoring, and catheterization procedures. The provided information does not include the company's founding story beyond its establishment in 1978, and details regarding its original founders are Unknown. UTMD's labor-and-delivery portfolio includes fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools used in childbirth. In neonatal care, the company supplies DISPOSA-HOOD infant respiratory hoods, GESCO umbilical vessel catheters, PALA-NATE silicone oral protection devices, and MYELO-NATE lumbar sampling kits. It also offers products used in broader hospital settings, including DELTRAN PLUS blood-pressure monitoring systems, disposable peritoneal dialysis sets under the DIALY-NATE name, URI-CATH urinary drainage systems, NUTRI-CATH and NUTRI-LOK feeding devices, HEMO-NATE disposable filters, catheterization procedure trays, disposable pressure transducers, related accessories, and molded parts. A substantial portion of the portfolio addresses women's health and gynecological procedures. Products include the LETZ system for excising cervical intraepithelial neoplasia and other lower-genital-tract lesions, FINESSE+ generators, loop, ball, and needle electrodes, FILTRESSE evacuators, Femcare trocars and cannulae, EPITOME and OptiMicro electrosurgical devices, Filshie Clip female surgical contraception devices, PATHFINDER PLUS endoscopic irrigation devices, suprapubic catheterization products, LIBERTY urinary-incontinence treatment and control systems, ENDOCURETTE uterine endometrial sampling devices, TVUS/HSG-Cath products for assessing uterine abnormalities and bleeding, and the LUMIN uterine manipulator for laparoscopic procedures. UTMD serves neonatal intensive care units, labor-and-delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. Distribution combines direct customer service and sales teams with independent consultants and manufacturer representatives. The provided data does not identify specific countries, international revenue percentages, named major customers, market-share figures, or a quantified competitive ranking; these details are Unknown. The company's stated market position is therefore best characterized as a specialized medical-device supplier with a diversified product range concentrated in maternity care, neonatal care, and women's health.

What Products and Services Does UTMD Offer?

• Manufactures fetal monitoring accessories and vacuum-assisted delivery systems for labor and delivery departments.
• Supplies neonatal devices including respiratory hoods, umbilical vessel catheters, oral protection devices, and lumbar sampling kits.
• Produces blood-pressure monitoring systems, disposable pressure transducers, dialysis sets, urinary drainage systems, feeding devices, and filters.
• Provides catheterization procedure trays and related accessories and molded parts for healthcare procedures.
• Offers women's-health and gynecological products including electrosurgical systems, electrodes, evacuators, trocars, cannulae, and laparoscopic instruments.
• Supplies contraception, endoscopic irrigation, suprapubic catheterization, urinary-incontinence, uterine-sampling, uterine-assessment, and uterine-manipulation products.
• Distributes products through direct customer service and sales teams, independent consultants, and manufacturer representatives.

How Does UTMD Make Money?

• Generates revenue by creating, manufacturing, and supplying medical devices and related accessories to healthcare customers.
• Sells disposable products such as filters, catheters, pressure transducers, dialysis sets, feeding devices, and procedure supplies.
• Provides equipment-linked and procedural products, including electrosurgical generators, electrodes, monitoring systems, laparoscopic instruments, and gynecological tools.
• Reaches customers through direct service and sales teams, independent consultants, and manufacturer representatives.
• Serves hospitals, neonatal intensive care units, labor-and-delivery wards, outpatient clinics, women's-health centers, and physicians' offices.

What Industry Does UTMD Operate In?

UTMD operates in the healthcare sector's medical-instruments-and-supplies industry, with a specialized focus on labor and delivery, neonatal intensive care, women's health, gynecological procedures, urinary care, dialysis, feeding, and hospital catheterization. Its competitive landscape includes medical-device manufacturers and suppliers serving overlapping procedural categories, but the source data does not provide FMP peer tickers, named competitors, market sizes, industry growth rates, or UTMD market share. Accordingly, specific industry growth percentages, market-value estimates, and relative competitive rankings are Unknown. The company's positioning is supported by product breadth across disposable devices, electrosurgical equipment, procedure trays, monitoring accessories, and specialty instruments.

Who Are UTMD's Key Customers?

• Labor-and-delivery departments and hospital maternity wards.
• Neonatal intensive care units and healthcare providers treating newborns.
• Women's-health centers, gynecological departments, outpatient clinics, and physicians' offices.
• Hospitals and clinical facilities requiring monitoring, catheterization, dialysis, urinary-care, feeding, and procedural devices.
• Healthcare providers performing laparoscopic, electrosurgical, uterine-assessment, contraception, or urinary-incontinence procedures.

Company Profile

Utah Medical Products, Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Midvale, US. The company is led by CEO Kevin L. Cornwell. UTMD has traded publicly since 1999.

Return on equity for Utah Medical Products, Inc. stands at 8.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 8.4%, showing how much profit it generates from its asset base. UTMD trades at a trailing price-to-earnings ratio of 18.36, below the Healthcare sector average of ~23x. Its free cash flow yield is 5.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 48.62 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 4.6%, the inverse of the P/E and a quick read on earnings relative to price.

UTMD Valuation & Market Position

With a $227M market cap, Utah Medical Products, Inc. sits in the micro-cap segment of the market. Relative to its peer group, UTMD's quantitative score of 87/100 is above the peer average of 68/100.

Quarterly Financial Performance: Utah Medical Products, Inc.

Revenue for Utah Medical Products, Inc. came in at $8.5M during Q2 2026, a 2.2% contraction versus the preceding quarter. The company recorded net income of $2.7M, with diluted EPS of $0.84. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, UTMD averaged $0.82 in diluted EPS.

Utah Medical Products, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 57.31 places it in the safe zone, indicating low near-term bankruptcy risk.

Utah Medical Products, Inc. has missed Wall Street's EPS estimate in 3 of its last 3 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 27.4% below estimates on average.

UTMD Financials

UTMD Latest News

No recent news available for UTMD.

UTMD Analyst Consensus

UTMD MoonshotScore

UTMD Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources